Bristol-Myers Squibb Company (FRA:BRM)
Germany · Delayed Price · Currency is EUR 37.73
-1.13 (-2.90%)
Last updated: Oct 23, 2025, 5:35 PM CET
FRA:BRM Revenue
Bristol-Myers Squibb Company had revenue of $12.27B USD in the quarter ending June 30, 2025, with 0.56% growth. This brings the company's revenue in the last twelve months to $47.70B, up 2.57% year-over-year. In the year 2024, Bristol-Myers Squibb Company had annual revenue of $48.30B with 7.32% growth.
Revenue (ttm)
$47.70B
Revenue Growth
+2.57%
P/S Ratio
1.92
Revenue / Employee
$1.40M
Employees
34,100
Market Cap
77.81B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.30B | 3.29B | 7.32% |
| Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
| Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
| Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
| Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 139.36B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Aktiengesellschaft | 78.30B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Siemens Energy AG | 38.39B |
| SAP SE | 36.49B |
| Deutsche Bank Aktiengesellschaft | 30.07B |
Bristol-Myers Squibb Company News
- 16 hours ago - Interesting BMY Put And Call Options For December 5th - Nasdaq
- 1 day ago - Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks - Nasdaq
- 2 days ago - The Play On Bristol-Myers Squibb - Seeking Alpha
- 6 days ago - Validea Detailed Fundamental Analysis - BMY - Nasdaq
- 6 days ago - Bristol Myers (BMY) Reports Positive Trial Data on Cancer Drug - GuruFocus
- 6 days ago - Bristol Myers Squibb (BMY) Reports Promising Phase I Trial Results for Iza-bren - GuruFocus
- 6 days ago - Bristol Myers Squibb, SystImmune report data from lung cancer trial - Seeking Alpha
- 7 days ago - HopeHealth Launches Phase 3 Clinical Trial Site To Advance Lupus Research With Support From Bristol Myers Squibb - Wallstreet:Online